Filing Flows › SkinHealth Systems (SKIN) › R&D spending
SkinHealth Systems (SKIN) R&D spending by quarter
SkinHealth Systems' R&D spending was $1.7M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 7 quarters it ranged from $998K (Q1 2025) to $1.7M (Q3 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.7M | +18% | -2% |
| Q2 2026 | $1.4M | +28% | +12% |
| Q1 2026 | $1.1M | -34% | +10% |
| Q4 2025 | $1.7M | -1% | — |
| Q3 2025 | $1.7M | +36% | — |
| Q2 2025 | $1.3M | +25% | — |
| Q1 2025 | $998K | — | — |
Q3 2026 at a glance
SkinHealth Systems, Q3 2026: revenue $69.2M (-2% year over year), operating margin 7.2%, net loss $888K, operating cash flow $11.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is SkinHealth Systems' R&D spending?
SkinHealth Systems' R&D spending was $1.7M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has SkinHealth Systems' R&D spending changed?
Over the last 7 quarters it ranged from $998K (Q1 2025) to $1.7M (Q3 2025).